Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petr Ostadal

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Lancet (London, England)|September 5, 2024
Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-upHolger Thiele, Jacob E Møller, Jose P S Henriques, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
Plos One|February 25, 2015
Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failureSimona Littnerova, Jiri Parenica, Jindrich Spinar, et al.
Clinical Cardiology|May 24, 2019
Hyperuricemia treatment in acute heart failure patients does not improve their long-term prognosis: A propensity score matched analysis from the AHEAD registryMarie Pavlusova, Jiri Jarkovsky, Klara Benesova, et al.
International Journal of Cardiology|May 19, 2015
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisationsMarkku S Nieminen, Kenneth Dickstein, Cândida Fonseca, et al.
International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2024
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trialZuzana Motovska, Ota Hlinomaz, Jan Mrozek, et al.
Drugs|November 4, 2024
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)Maciej Banach, Željko Reiner, Stanisław Surma, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Lancet (London, England)|September 5, 2024
Temporary mechanical circulatory support in infarct-related cardiogenic shock: an individual patient data meta-analysis of randomised trials with 6-month follow-upHolger Thiele, Jacob E Møller, Jose P S Henriques, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|May 15, 2020
Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)Michelle Samuel, Jean-Claude Tardif, Paul Khairy, et al.
Circulation|May 24, 2019
Effect of Alirocumab on Mortality After Acute Coronary SyndromesPhilippe Gabriel Steg, Michael Szarek, Deepak L Bhatt, et al.
The New England Journal of Medicine|November 17, 2019
Efficacy and Safety of Low-Dose Colchicine after Myocardial InfarctionJean-Claude Tardif, Simon Kouz, David D Waters, et al.
Plos One|February 25, 2015
Positive influence of being overweight/obese on long term survival in patients hospitalised due to acute heart failureSimona Littnerova, Jiri Parenica, Jindrich Spinar, et al.
Clinical Cardiology|May 24, 2019
Hyperuricemia treatment in acute heart failure patients does not improve their long-term prognosis: A propensity score matched analysis from the AHEAD registryMarie Pavlusova, Jiri Jarkovsky, Klara Benesova, et al.
International Journal of Cardiology|May 19, 2015
The patient perspective: Quality of life in advanced heart failure with frequent hospitalisationsMarkku S Nieminen, Kenneth Dickstein, Cândida Fonseca, et al.
International Journal of Cardiology|October 17, 2019
A pragmatic approach to the use of inotropes for the management of acute and advanced heart failure: An expert panel consensusDimitrios Farmakis, Piergiuseppe Agostoni, Loant Baholli, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|October 21, 2024
Cangrelor versus crushed ticagrelor in patients with acute myocardial infarction and cardiogenic shock: rationale and design of the randomised, double-blind DAPT-SHOCK-AMI trialZuzana Motovska, Ota Hlinomaz, Jan Mrozek, et al.
Drugs|November 4, 2024
2024 Recommendations on the Optimal Use of Lipid-Lowering Therapy in Established Atherosclerotic Cardiovascular Disease and Following Acute Coronary Syndromes: A Position Paper of the International Lipid Expert Panel (ILEP)Maciej Banach, Željko Reiner, Stanisław Surma, et al.
Pageof 8